Last Updated on January 25, 2020 by HepFree NYC
The NYC Health Department has released its 2016 Hepatitis B and C Annual Report, and this past year amended the Health Code to improve complete hepatitis C diagnostic testing and outcomes in NYC.
Fieldwork East Inc., is an independent national multi-office market research facility, specializing in medical research for new product development.
The NYS Medicaid Drug Utilization Review Board met on September 15, 2016 and added Epclusa (GT 2 and 3) and Viekira XR to the preferred prescription medication list.
The Hepatitis A, B and C in NYC: 2021 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
Find New York City and State viral hepatitis surveillance data to help with reports, grant applications, advocacy and more!
On February 6th, in our State's Capital, join hundreds of people living with Hep C, elected officials, healthcare professionals, services providers and people for a day of advocacy and action.
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010.Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of ...
